Sambica HCT Tablet 5/20/12.5 mg

Adult dose

This drug should be taken once daily with water, regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning). The recommended dosing is as follows: - 5/20/12.5 mg: Administered to patients whose blood pressure is not adequately controlled with amlodipine/olmesartan medoxomil 5/20 mg combination therapy. - 5/40/12.5 mg: Administered to patients whose blood pressure is not adequately controlled with amlodipine/olmesartan medoxomil 5/40 mg combination therapy or this drug 5/20/12.5 mg.

Child dose

The safety and efficacy of this drug in pediatric patients under 18 years of age have not been established, so its use is not recommended.

This drug may cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, and therefore, should be discontinued immediately upon confirmation of pregnancy. Patients who are allergic to this drug or any of its components, pregnant or breastfeeding women, and patients with severe hypotension or heart, kidney, or liver diseases should not use this drug. Patients with reduced blood volume or poor kidney function, patients with liver disease, etc., should be particularly careful when using this drug, and blood pressure, kidney function, and electrolyte levels should be regularly monitored during treatment. This drug lowers blood pressure, and may cause symptoms of hypotension, as well as dizziness or drowsiness, so caution should be exercised when driving or operating dangerous machinery. This drug may interact with other medications, therefore, it is important to consult with a doctor or pharmacist when taking it alongside lithium, non-steroidal anti-inflammatory drugs (NSAIDs), or other antihypertensive agents. Long-term use of this drug may lead to electrolyte imbalances, so potassium, sodium, calcium levels, etc., should be periodically checked through blood tests. Women who are pregnant or planning to become pregnant should consult with healthcare professionals before taking this drug, and breastfeeding women should also avoid taking this drug. The safety and efficacy of this drug have not been established in pediatric patients under 18 years of age, so its use is not recommended. In the case of overdose, symptoms such as hypotension and palpitations may occur, so immediate medical assistance should be sought. This drug should be stored in a tightly closed container to protect it from light and moisture and kept out of reach of children, and it is recommended not to transfer it to another container.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blistering, skin peeling, pain in the oral or ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory difficulties with cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis, urination

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory tract infection
• nasopharyngitis
• urinary tract infection
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This drug should be stored in a tightly sealed container to protect it from air and moisture and should be stored at room temperature between 1 to 30 degrees Celsius. By storing it this way, the drug's effectiveness can be maintained and deterioration prevented.

Appearance

White-orange round film-coated tablets

Package unit

30 tablets (10 tablets/Alu-Alu × 3)